SAM MED: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
SAM MED
Largest movements
- Intangible fixed assets -€80,000
down €80,000 (-50.0%), from €160,000 to €80,000
- Receivables within one year +€18,590
up €18,590 (+97.8%), from €19,006 to €37,596
of which Other amounts receivable: +€19,291
- Cash +€13,233
up €13,233 (+5.7%), from €233,356 to €246,589
mainly Depreciation (+€81,771) and Net result for the year (+€29,074)
- Other debts -€78,137
down €78,137 (-45.1%), from €173,434 to €95,296
- Reserves +€28,241
up €28,241 (+12.3%), from €228,810 to €257,051
- Gross operating margin -€4,581
down €4,581 (-3.6%), from €126,077 to €121,496
- Depreciation -€1,382
down €1,382 (-1.7%), from €83,154 to €81,771
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €415,347 | €364,886 | -€50,461 | -12.1% |
| Fixed assets | 21/28 | €161,771 | €80,000 | -€81,771 | -50.5% |
| Intangible fixed assets | 21 | €160,000 | €80,000 | -€80,000 | -50.0% |
| Tangible fixed assets | 22/27 | €1,771 | €0 | -€1,771 | -100.0% |
| Plant, machinery and equipment | 23 | €1,771 | €0 | -€1,771 | -100.0% |
| Current assets | 29/58 | €253,576 | €284,886 | +€31,310 | +12.3% |
| Amounts receivable within one year | 40/41 | €19,006 | €37,596 | +€18,590 | +97.8% |
| Trade receivables | 40 | €701 | €0 | -€701 | -100.0% |
| Other amounts receivable | 41 | €18,305 | €37,596 | +€19,291 | +105.4% |
| Cash at bank and in hand | 54/58 | €233,356 | €246,589 | +€13,233 | +5.7% |
| Deferred charges and accrued income | 490/1 | €1,213 | €701 | -€512 | -42.2% |
| Total equity and liabilities | 10/49 | €415,347 | €364,886 | -€50,461 | -12.1% |
| Equity | 10/15 | €238,810 | €267,051 | +€28,241 | +11.8% |
| Contributions | 10/11 | €10,000 | €10,000 | = | 0.0% |
| Reserves | 13 | €228,810 | €257,051 | +€28,241 | +12.3% |
| Distributable reserves | 133 | €228,810 | €257,051 | +€28,241 | +12.3% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €176,537 | €97,836 | -€78,702 | -44.6% |
| Amounts payable within one year | 42/48 | €176,537 | €97,836 | -€78,702 | -44.6% |
| Trade debts | 44 | €397 | €274 | -€123 | -31.0% |
| Suppliers | 440/4 | €397 | €274 | -€123 | -31.0% |
| Taxes, remuneration and social security | 45 | €2,707 | €2,266 | -€441 | -16.3% |
| Taxes | 450/3 | €2,707 | €2,266 | -€441 | -16.3% |
| Other amounts payable | 47/48 | €173,434 | €95,296 | -€78,137 | -45.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €83,154 | €81,771 | -€1,382 | -1.7% |
| Other operating charges | 640/8 | €451 | €465 | +€14 | +3.2% |
| Gross operating margin | 9900 | €126,077 | €121,496 | -€4,581 | -3.6% |
| Operating profit (loss) | 9901 | €42,472 | €39,259 | -€3,213 | -7.6% |
| Financial income | 75/76B | €938 | €934 | -€4 | -0.4% |
| Recurring financial income | 75 | €938 | €934 | -€4 | -0.4% |
| Financial charges | 65/66B | €183 | €130 | -€53 | -28.8% |
| Recurring financial charges | 65 | €183 | €130 | -€53 | -28.8% |
| Profit (loss) for the period before taxes | 9903 | €43,227 | €40,063 | -€3,164 | -7.3% |
| Income taxes | 67/77 | €11,633 | €10,989 | -€644 | -5.5% |
| Profit (loss) for the period | 9904 | €31,594 | €29,074 | -€2,520 | -8.0% |
| Profit (loss) for the period to be appropriated | 9905 | €31,594 | €29,074 | -€2,520 | -8.0% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.